Más Dermatología, n.º 34

Suñer Ollé E. Ácido tranexámico en dermatología Más Dermatol. 2021;34:21-27 doi:10.5538/1887-5181.2021.34.21 27 BIBLIOGRAFÍA 1. Watts G. Utako Okamoto. Lancet. 2016;387(10035):2286. 2. Forbat E, Al-Niaimi F, Ali FR. The emerging importance of tranexamic acid in dermatology. Clin Exp Dermatol. 2020; 45(4):445-9. 3. Jurado Santa-Cruz F, Ortiz-Lobato L, Morales Sánchez MA, Peralta Pedrero ML. Ácido tranexámico oral y tópico en el tratamiento del melasma. Revisión sistemática. Rev Cent Der- matol Pascua. 2019;28(2):53-64. 4. Lee HC, Thng TGS, Goh CL. Oral tranexamic acid (TA) in the treatment of melasma: a retrospective analysis. J Am Acad Dermatol. 2016;75(2):385-92. 5. Menon A, Eram H, Kamath PR, Goel S, Babu AM. A split face comparative study of safety and efficacy of microneedling with tranexamic acid versus microneedling with vitamin C in the treatment of melasma. Indian Dermatol Online J. 2019; 11(1):41-5. 6. Atefi N, Dalvand B, Ghassemi M, Mehran G, Heydarian A. Therapeutic effects of topical tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatol Ther (Heidelb). 2017;7(3):417-24. 7. Yoo J, Ahn H, Kim MS, Jue MS, Choi KH. Efficacy of topical tranexamic acid in treatment of melasma. Korean J Dermatol. 2017;55(5):283-9. 8. Zenjari L, Elfetoiki FZ, Hali F, Skalli H, Chiheb S. Oral tranexa- mic acid in the treatment of lichen planus pigmentosus: a prospective study of 20 cases. Ann Dermatol Venereol. 2020; 147(12):818-22. 9. Kwon HJ, Suh JH, Ko EJ, Kim BJ. Combination treatment of propranolol, minocycline, and tranexamic acid for effective control of rosacea. Dermatol Ther. 2017;30(3). 10. Li Y, Xie H, Deng Z, Wang B, Tang Y, Zhao Z, et al. Tranexamic acid ameliorates rosacea symptoms through regulating im- mune response and angiogenesis. Int Immunopharmacol. 2019;67:326-34. 11. Jakhar D, Kaur I, Misri R. Topical 10% tranexamic acid for erythematotelangiectatic steriod induced rosacea. J Am Acad Dermatol. 2020;S0190-9622(20)30047-5. 12. Tranexamic acid. Cosmetic Ingredient Database (CosIng). European Commission, Internal Market, Industry, Entrepre- neurship and SME’s. Disponible en: https://ec.europa.eu/ growth/tools-databases/cosing/index.cfm?fuseaction=search. details_v2&id=80291 13. Meeting of the Working Group on Cosmetic Products (23-24 October 2014). European Commission, Health and Consumers Directorate-General (14/SANCO/COS/WG/20). 14. Scientific Committee on Consumer Safety (SCCS). European Commission, Scientific Committees. Disponible en: https:// ec.europa.eu/health/scientific_committees/consumer_safety_ es 15. Farmakologisk aktive stoffer i kosmetikk. Disponible en: https:// www.mattilsynet.no/kosmetikk/stoffer_i_kosmetikk/farmako- logisk_aktive_stoffer_i_kosmetikk.9856

RkJQdWJsaXNoZXIy MTAyMDQzMg==